Arise Lab Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 8 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 18.36%
- Profit Growth -15.41%
- Ebitda -15.41%
- Net Worth 45.22%
- Total Assets 18.06%
About Arise Lab
Arise Lab Private Limited (ALPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 29 November 2016 (Eight years and two months 16 days old ). Its registered office is in Vadodara, Gujarat, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Niraj Shah, Neelu Agrawal, and Palash Kavediya serve as directors at the Company.
Company Details
-
Location
Vadodara, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24304GJ2016PTC094514
-
Company No.
094514
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
29 Nov 2016
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Arise Lab?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Niraj Shah
|
Director | 29-Nov-2016 | Current |
|
Neelu Agrawal
|
Director | 29-Nov-2016 | Current |
|
Palash Kavediya
|
Director | 13-Jan-2024 | Current |
Financial Performance of Arise Lab.
Arise Lab Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 18.36% increase. The company also saw a substantial fall in profitability, with a 15.41% decrease in profit. The company's net worth Soared by an impressive increase of 45.22%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Arise Lab?
In 2023, Arise Lab had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Arise Bio- Care Private LimitedNiraj Shah is a mutual person
-
Nimeru Healthcare And Cosmetics Private LimitedNiraj Shah is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Arise Lab?
Unlock and access historical data on people associated with Arise Lab, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Arise Lab, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Arise Lab's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.